"Exactly… the company cannot promote DCVax-L without regulatory approval to do so."
Another lesson nwbo learned the hard way back in 2014-5.
Imagine if they had partner who knows the trial process, has experience with regulators, understood stock exchange regulations and all the pitfalls of being a public company. But Linda Powers bizarrely believed that a partner would only bring cash.
Market Data 
Markets 
AI
